Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Srikanth Talluri, Ph.D.

Concepts (167)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Srikanth Talluri's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Srikanth Talluri has written about over time.
G1 Phase, 1 publications between 2009 and 2009, average publication date December 2009. Heterochromatin, 2 publications between 2009 and 2013, average publication date December 2011. Chromatin Assembly and Disassembly, 1 publications between 2012 and 2012, average publication date August 2012. E2F Transcription Factors, 3 publications between 2009 and 2014, average publication date September 2012. Retinoblastoma Protein, 7 publications between 2009 and 2014, average publication date April 2013. Proto-Oncogene Proteins p21(ras), 1 publications between 2013 and 2013, average publication date August 2013. Tumor Suppressor Proteins, 1 publications between 2013 and 2013, average publication date December 2013. Mutation, 7 publications between 2009 and 2021, average publication date August 2016. DNA Damage, 3 publications between 2013 and 2021, average publication date January 2018. Cell Transformation, Neoplastic, 2 publications between 2013 and 2023, average publication date June 2018. Multiple Myeloma, 7 publications between 2017 and 2023, average publication date September 2020. Genomic Instability, 4 publications between 2018 and 2023, average publication date April 2021. Neoplasm Proteins, 1 publications between 2021 and 2021, average publication date October 2021.

To see the data from this visualization as text, click here.
Talluri's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (167)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.